Parental Decision Making Regarding COVID-19 Vaccines for Children under Age 5: Does Decision Self-Efficacy Play a Role?

Author:

Allen Jennifer D.1ORCID,Matsunaga Masako2ORCID,Lim Eunjung2,Zimet Gregory D.3,Nguyen Kimberly H.4,Fontenot Holly B.5ORCID

Affiliation:

1. Department of Community Health, Tufts University School of Arts and Sciences, 574 Boston Ave, Medford, MA 02155, USA

2. Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA

3. Department of Pediatrics, Indiana University School of Medicine, 410 West 10th Street, Suite 1001, Indianapolis, IN 46202, USA

4. Department of Public Health and Community Medicine, Tufts University Medical School, 136 Harrison Ave, Boston, MA 02111, USA

5. Nancy Atmospera-Walch School of Nursing, University of Hawaii at Manoa, 2528 McCarthy Mall, Webster Hall, Honolulu, HI 96822, USA

Abstract

Background: COVID-19 vaccines are now available under Emergency Use Authorization for children ages 6 months to 5 years. We examined parents’ intentions to vaccinate their children under the age of 5 years and assessed whether their confidence in making an informed decision about vaccination (decision self-efficacy) was associated with these intentions. Method: We conducted a cross-sectional online survey of U.S. parents between 23 March and 5 April 2022. We examined associations between parental intention to vaccinate their young children (<age 5 years) and confidence in vaccine decision making (decision self-efficacy). A multivariable multinomial logistic regression model was used to obtain adjusted odds ratios (AORs) and 95% confidence intervals (CIs) of parental intention (categorized as intend to vaccinate, unsure, or do not intend to vaccinate). Results: Of the 591 parents in this sample, 49% indicated that they intended to vaccinate their child(ren), 29% reported that they would not, and 21% were undecided. In bivariate analyses, race/ethnicity, health insurance, flu vaccination in the past 12 months, and parental COVID-19 vaccination status were significantly related to parental intention to vaccinate their child(ren). In the multivariable analyses, which controlled for these factors, parents who intended to vaccinate their child(ren) had greater confidence in their ability to make informed decisions about COVID-19 vaccinations compared to those who were unsure about vaccination. Each one standard deviation in the Decision Self-Efficacy score was associated with a 39% increase in intention to vaccinate one’s child versus being unsure about vaccination (AOR 1.39, 95% CI 1.09, 1.77). Conclusions: Parents who are unsure about vaccinating their children against COVID-19 may benefit from interventions designed to increase their ability to obtain, understand, and utilize information to make informed decisions.

Funder

Tufts University Office of the Vice Provost of Research

University of Hawaii at Manoa, Frances A. Matsuda Chair

Ola HAWAII

National Institute of Health

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference48 articles.

1. American Academy of Pediatrics (2022, December 15). Children and COVID-19: State-Level Data Report. A Joint Report from the American Academy of Pediatrics and the Children’s Hospital Association. Available online: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/#:~:text=As%20of%20December%208th%2C%20almost,in%20the%20past%204%20weeks.

2. Centers for Disease Control and Prevention (2021, June 09). Coronavirus Disease 2019 (COVID-19). Published 11 February 2020, Available online: https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/transmission_k_12_schools.html.

3. SARS-CoV-2–Associated Deaths Among Persons Aged <21 Years—United States, 12 February–31 July 2020;Bixler;MMWR. Morb. Mortal. Wkly. Rep.,2020

4. SARS-CoV-2 infection in children and implications for vaccination;Nathanielsz;Pediatr. Res.,2022

5. Immunology of SARS-CoV-2 infection in children;Chou;Nat. Immunol.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3